This expectation of Mahle/Maeda/Gray leading the rotatation followed by Ryan is surely a hope that should not be plan A. Ryan is there, but two of the other three are total questions, and Paddack is too.
I think Mahle will undergo TOS surgery, and we may not see him at all. If he does come back this year, he will see the same results as the last two starts. Sad, but that is my prediction. I think the trade will prove a total bust and Mahle was damaged as he was acquired. Like Paddack, the FO had decided he was the middle of the road pitcher that had spin rates they liked as is their formula, and did the deal even though he was in question as they did the deal. The desperate position the team was in beause of a lack of supplying quality pitching in the off season even though it was clear that was the most urgent need. Both of Mahle and Paddack. History was known, and desregarded or determined OK for the future, even if they were lost for a year and couldn't help now as was the immediate need. Mahle's case is the most concerning, as he says he feels fine, but cannot perform. To pencil him in at all is nuts. He should only be considered depth at this point, and in any decisions to create a starting staff for 2023. We will prove to be fleeced once again.
Just a prediction. I hope they all both become of value, because so far........ total bust, and we needed them now,
Madea coming back from TJ..... also in question but more expected.